Revolution Medicines, Inc. (RVMD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:51PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 5.90B |
| Enterprise value | 4.13B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 350.00 |
| Price/book (mrq) | 3.23 |
| Enterprise value/revenue | 357.01 |
| Enterprise value/EBITDA | -9.61 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.54 |
| 52-week change 3 | 47.51% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 38.73 |
| 52-week low 3 | 15.44 |
| 50-day moving average 3 | 31.59 |
| 200-day moving average 3 | 28.19 |
Share statistics
| Avg vol (3-month) 3 | 1.45M |
| Avg vol (10-day) 3 | 1.67M |
| Shares outstanding 5 | 164.69M |
| Implied shares outstanding 6 | 164.69M |
| Float 8 | 160.84M |
| % held by insiders 1 | 2.46% |
| % held by institutions 1 | 96.14% |
| Shares short (28 Mar 2024) 4 | 12M |
| Short ratio (28 Mar 2024) 4 | 7.14 |
| Short % of float (28 Mar 2024) 4 | 7.56% |
| Short % of shares outstanding (28 Mar 2024) 4 | 7.29% |
| Shares short (prior month 29 Feb 2024) 4 | 17.15M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -20,819.81% |
Management effectiveness
| Return on assets (ttm) | -20.08% |
| Return on equity (ttm) | -34.75% |
Income statement
| Revenue (ttm) | 11.58M |
| Revenue per share (ttm) | 0.10 |
| Quarterly revenue growth (yoy) | -95.20% |
| Gross profit (ttm) | N/A |
| EBITDA | -456.68M |
| Net income avi to common (ttm) | -436.37M |
| Diluted EPS (ttm) | -3.86 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.85B |
| Total cash per share (mrq) | 11.25 |
| Total debt (mrq) | 87.94M |
| Total debt/equity (mrq) | 4.82% |
| Current ratio (mrq) | 13.06 |
| Book value per share (mrq) | 11.09 |
Cash flow statement
| Operating cash flow (ttm) | -350.57M |
| Levered free cash flow (ttm) | -155.2M |
© 2024 Yahoo. All rights reserved.